S. Crettol

Discipline

Psychologie (6) Sociologie (1)

Type de document

Articles (15) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Patients (11) Patients (11) risque (9) Treatment (9) Risk (9) Swiss (7) Human beings (7) cohorte (7) Drugs (6) association (5) dose (5) Weight gain (5) Social groups (5) Body mass index (5) Models (5) poids (4) analyse (4) effet (4) âge (4) Obesity (4) Older people (4) Age (4) Metabolic syndrome (4) Weight (4) Age (4) Analysis (4) temps (durée) (3) organe (3) modèle (3) métabolisme (3)

Documents écrit par S. Crettol (15) | parle de S. Crettol (0)

Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis.
J. Sjaarda et al.
The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples.
B.I. Perry et al.
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.
N. Laaboub et al. (17 mai 2022)
Olanzapine-associated dose-dependent alterations for weight and metabolic parameters in a prospective cohort.
G. Schoretsanitis et al.
Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity.
V. Guinchat et al. (2022)
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.
C.B. Eap et al.
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort.
N. Laaboub et al. (2021)
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.
L. Quteineh et al.
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
L. Quteineh et al.
Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers.
F. Vandenberghe et al.
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant Populations.
N. Saigi-Morgui et al. (2016)
Eine unerwünschte Wirkung von Methadon und Moxifloxacin
E. Liakoni et al. (2016)
Can Valproic Acid be an Inducer of Clozapine Metabolism?
F.J. Diaz et al. (2014)
Cannabis and benzodiazepines as determinants of methadone trough plasma concentration variability in maintenance treatment: a transnational study.
R. Hallinan et al. (2009)
Could pharmacogenetic data explain part of the interindividual sensitivity to methadone-induced respiratory depression?
S. Crettol et al. (2007)